Lifetime Achievement Award 

2025 CAPO Lifetime Achievement Award Recipient: Fred Ashbury, BA, MA, PhD, MACE, Chief Scientific Officer


30+ Years of Cancer Leadership Experience
Former CSO with OpTx Corp
Former Senior Executive with Cancer Care Ontario

Fred is a co-founder and Chief Scientific Officer at VieCure. He is responsible for developing and maintaining VieCure’ s oncology clinical content library, genomic-science knowledge identification, classification and codification, and the design and implementation of the diagnostic, treatment (including precision medicine strategy), toxicity management, survivorship and palliative/end-of-life care rules that underpin our platform.

He is a Full Professor (Adjunct) in the Department of Internal Medicine-Medical Oncology, The Ohio State University and in the Department of Oncology, University of Calgary and has held academic appointments at the University of Toronto and McGill University. He has published 170+ peer-reviewed articles, book chapters and major reports in oncology health services delivery, quality in cancer care, and supportive care. He is an invited speaker at major national and international oncology conferences. He is the Editor-in-Chief for the top-ranked international journal Supportive Care in Cancer and sits on the editorial board of British Medical Journal-Open, and SN Clinical Comprehensive Medicine.  He has been a reviewer for more than 20 oncology and public health journals for the past 25 years.  Fred is a former senior executive with the National Cancer Institute of Canada, Cancer Care Ontario, the Alberta Cancer Board, OpTx Corporation, and BridgeSite Clinical Research. Fred founded two successful healthcare management consultancies with clients in the US, Canada, UK, Germany, and Australia.

Fred has mentored oncology practices and networks worldwide to establish guideline-based clinical practice standards and care plans, define key performance indicators and quality metrics based on current evidence and practice, used to establish practice accountability, reporting and quality improvement.

He is a member of the Canadian Association of Psychosocial Oncology (CAPO), including past Board Member and currently a member of CAPO’s Research Advisory Committee.  He is also a member of the American Society of Clinical Oncology.  Fred is currently a member of the Board (ex officio) for the Multi-National Association of Supportive Care in Cancer (MASCC) and Chair of the Guidelines Committee, MASCC.

Submissions are now closed.

This annual award honours a CAPO/ACOP member who, in the opinion of the Awards Committee and the Board of Directors of the association, has made exceptional and enduring career contributions to Psychosocial Oncology.

  • This award shall be presented to recognize a Canadian individual who, in the opinion of the Awards Committee and the Board of Directors of the association, has made exceptional and enduring career contributions to Psychosocial Oncology.

  • Eligibility is limited to members in good standing of CAPO (for at least 2 years prior to the nomination).

  • Award recipients must register and attend the annual CAPO conference (in person or virtually) in order to be eligible.
  • Nominators do not need to be CAPO members. It is the responsibility of the nominators to obtain permission from the nominee to put their name forward for the award.
  • The Lifetime Achievement Award replaces the original CAPO Award of Excellence. The winners of the original CAPO Award of Excellence are ineligible to receive the Lifetime Achievement Award.

  • Click here to view the Lifetime Achievement Award Terms of Reference.

Application Process

  • Application for the award will consist of a curriculum vitae or resume of the nominee, together with a letter of nomination and one letter of reference from individuals familiar with the nominee’s contributions. The letter of nomination will specifically state why the nominee is deserving of the award by providing evidence for how the individual has, over the course of their career, given exceptional and enduring career contributions to Psychosocial Oncology in the areas of research, education, clinical practice, and/or policy.

  • Complete nomination packages must be submitted ONLINE to the Chair(s) of the Awards Committee (c/o the CAPO office) by no later than February 14, 2025

  • Nominations and supporting documentation can be submitted in either French or English.

  • If no suitable recipients are nominated, no award will be given.

  • There is no monetary value to this award.

CLICK HERE TO SUBMIT FOR LIFETIME ACHIEVEMENT AWARD

Recent winners of the Life Time Achievement award:

  • 2023 Dr. Carole Mayer (ON)
  • 2022 – Dr. Maru Barerra (ON)
  • 2020 – Dr. Doris Howell (ON)

  • 2019 – Dr. Thomas Hack (MB)

  • 2018 – Dr. Gerald M. Devins (ON)

  • 2017 – Dr. Joan Bottorff (BC)

  • 2016 – Gina MacKenzie (BC)

  • 2015 – Diane Manii (ON)

  • 2013 – Dr. Scott M. Sellick (ON)

  • 2012 – Dr. Gary Rodin (ON)

  • 2011 – Dr. Mary Jane Esplen (ON)

  • 2010 – Dr. Harvey Max Chochinov (MB)

    Prior to 2010, this award was called the CAPO Award of Excellence. The prior winners of the CAPO Award of Excellence before the change in the award structure were:


  • 2009 – Esther Green (ON)

  • 2008 – Jill Taylor Brown (MB)

  • 2007 – Dr. Lesley Degner (MB)

  • 2006 – Dr. Zeev Rosberger (QC)

  • 2005 – Dr. Barry Bultz (AB)

  • 2004 – Dr. Margaret Fitch (ON)

The Canadian Association of
Psychosocial Oncology (CAPO)

189 Queen Street East, Suite 1
Toronto, ON M5A 1S2
P. 416-968-0207
[email protected]

Facebook Logo    twitter x logo    linkedin logo    linkedin logo

Privacy Policy | CAPO By-laws
© 1993-2025 - CAPO/ACOP

The Canadian Association of Psychosocial Oncology • Association Canadienne d'Oncologie Psychosociale
Website powered by Funnel Communications